The All Age Asthma Cohort (ALLIANCE) of the German Center for Lung Research (DZL), Pediatric Arm

Status: Recruiting
Location: See all (5) locations...
Study Type: Observational
SUMMARY

Despite its common occurrence, still little is known about pathomechanisms determining different wheeze and asthma trajectories and phenotypes in children, and those beginning in adulthood. Therefore, deciphering underlying determinants for different childhood and adult asthma phenotypes is urgently needed to develop personalized treatment approaches targeting distinct underlying mechanisms. Thereby, secondary prevention early in the disease process can also be achieved. The decoding of such mechanisms and their translation to the individual patient is the aim of the Disease Area Asthma Allergy of the 'German Centre for Lung Research' (DZL).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 6 months
Maximum Age: 18
Healthy Volunteers: t
View:

• informed consent by parents (and by children if age \> 8 years)

• age 6 months to 18 years

• term delivery (≥ 37 weeks)

• active/passive understanding of German

• age 6 months - \< 6 years: preschool wheeze (more than two episodes of wheeze during 12 months prior to inclusion)

• age at least 6 years: doctor diagnosed asthma (according to current guidelines)

Locations
Other Locations
Germany
University Children's Hospital Cologne, Department of Paediatric Allergology and Pneumology
RECRUITING
Cologne
Medizinische Hochschule Hannover, Biomedical Research in Endstage and Obstructive Lung Disease
RECRUITING
Hanover
Universitaetsklinikum Schleswig-Holstein, Klinik für Kinder- und Jugendmedizin, Airway Research Center North
RECRUITING
Lübeck
Klinik für Kinder- und Jugendmedizin, Universitaetsklinikum Giessen und Marburg GmbH, Universities of Giessen and Marburg Lung Center
RECRUITING
Marburg
Klinikum der Universitaet Muenchen, Comprehensive Pulmonary Center Munich
RECRUITING
Munich
Contact Information
Primary
Esther Zeitlmann, Diplom
esther.zeitlmann@med.uni-muenchen.de
+49894400
Backup
Bianca Schaub, MD
bianca.schaub@med.uni-muenchen.de
+49894400
Time Frame
Start Date: 2013-01
Estimated Completion Date: 2027-12
Participants
Target number of participants: 1500
Treatments
new-onset wheeze/asthma
children with inhaled or systemic corticosteroid-/leukotriene receptor antagonist-naïve wheeze/asthma, will undergo follow-up after initial recruitment
wheeze/asthma under controller therapy
children with wheeze/asthma, already under controller (inhaled or systemic corticosteroids or leukotriene receptor antagonist) therapy, will undergo follow-up after initial recruitment
healthy controls
healthy age- and sex-matched controls, will not undergo follow-up after initial recruitment
Related Therapeutic Areas
Sponsors
Collaborators: Biomedical Research in Endstage and Obstructive Lung Disease Hannover, Airway Research Center North, Comprehensive Pulmonary Center Munich, Universities of Giessen and Marburg Lung Center, German Center for Lung Research, Translational Lung Research Center Heidelberg, German Federal Ministry of Education and Research
Leads: LMU Klinikum

This content was sourced from clinicaltrials.gov